ACBYX
Price
$15.17
Change
+$0.11 (+0.73%)
Updated
Jun 26 closing price
Net Assets
104.86M
RLBEX
Price
$36.35
Change
+$0.27 (+0.75%)
Updated
Jun 26 closing price
Net Assets
247.64B
Interact to see
Advertisement

ACBYX vs RLBEX

Header iconACBYX vs RLBEX Comparison
Open Charts ACBYX vs RLBEXBanner chart's image
American Beacon Balanced Y
Price$15.17
Change+$0.11 (+0.73%)
VolumeN/A
Net Assets104.86M
American Funds American Balanced R4
Price$36.35
Change+$0.27 (+0.75%)
VolumeN/A
Net Assets247.64B
ACBYX vs RLBEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ACBYX vs. RLBEX commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACBYX is a Buy and RLBEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 248B vs. ACBYX (105M). RLBEX (1.90) and ACBYX (1.86) have matching dividends . ACBYX was incepted earlier than RLBEX: ACBYX (15 years) vs RLBEX (23 years). ACBYX (0.94) is less costly to investors than RLBEX (0.59). RLBEX is a more actively managed with annual turnover of: 44.00 vs. ACBYX (38.00). RLBEX has a lower initial minimum investment than ACBYX: RLBEX (250) vs ACBYX (100000). RLBEX annual gain was more profitable for investors over the last year : 7.34 vs. ACBYX (1.52). RLBEX return over 5 years is better than : 42.62 vs. ACBYX (18.30).
ACBYXRLBEXACBYX / RLBEX
Total Expense Ratio0.940.59159%
Annual Report Gross Expense Ratio0.940.59159%
Fund Existence15 years23 years-
Gain YTD3.5796.71353%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets105M248B0%
Annual Yield % from dividends1.861.9098%
Returns for 1 year1.527.3421%
Returns for 3 years11.9432.6337%
Returns for 5 years18.3042.6243%
Returns for 10 years6.5565.7510%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HWC57.441.53
+2.74%
Hancock Whitney Corp
API3.820.06
+1.60%
Agora
QCRH68.000.76
+1.13%
QCR Holdings
BCE21.85-0.09
-0.41%
BCE
TXMD1.17-0.02
-1.68%
TherapeuticsMD